Benralizumab efficacy for patients with fixed airflow obstruction and severe, uncontrolled eosinophilic asthma
Author:
Funder
AstraZeneca
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine,Immunology and Allergy,Immunology
Reference18 articles.
1. Risk factors associated with irreversible airway obstruction in asthma: a systematic review and meta-analysis;Zhang;Biomed Res Int,2016
2. Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study;Lee;Chest,2007
3. Asthma, airflow limitation and mortality risk in the general population;Huang;Eur Respir J,2015
4. Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up;Contoli;J Allergy Clin Immunol,2010
5. Factors associated with persistent airflow limitation in severe asthma;ten Brinke;Am J Respir Crit Care Med,2001
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clinical characteristics of obese, fixed airway obstruction, exacerbation-prone phenotype and comorbidities among severe asthma patients: a single-center study;BMC Pulmonary Medicine;2024-02-09
2. Factors influencing poor response to type 2 targeted therapies in severe asthma: a retrospective cohort study;BMC Pulmonary Medicine;2023-12-05
3. The clinical efficacy of type 2 monoclonal antibodies in eosinophil-associated chronic airway diseases: a meta-analysis;Frontiers in Immunology;2023-04-11
4. Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction;Annals of Allergy, Asthma & Immunology;2023-02
5. Recent developments in the use of monoclonal antibodies targeting the type 2 cytokines for severe asthma treatment;Advances in Pharmacology;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3